PA-BENTLEY-SYSTEMS
15.6.2021 00:07:11 CEST | Business Wire | Press release
Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced the acquisition of SPIDA Software, developers of specialized software for the design, analysis, and management of utility pole systems. Founded in 2007 in Columbus, Ohio, SPIDA offers modeling, simulation, and data management software solutions to electric and communications utilities, and their engineering services providers, in the U.S. and Canada. The integration of SPIDA within Bentley’s OpenUtilities engineering software and grid digital twin cloud services will help address the challenges of transitioning to new renewable energy sources including for electric vehicle charging, of joint usage of utility poles to support broadband networks’ 5G expansion, and of modernizing and hardening the electric grid to maintain reliability and resilience.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210614005811/en/
Grid digital twins can provide utilities with immersive and engineering-accurate geospatial representations of their transmission and distribution assets, combining intelligent network and structural analysis with as-operated 3D and 4D physical reality. Bentley’s OpenUtilities grid digital twin solutions enable operators and power producers to evaluate grid trade-offs and opportunities, now spanning traditional and renewable sources and energy storage, as they provision services to meet demand. Digital twins advance asset health management by converging IT, OT, and ET (engineering modeling and simulations) to leverage infrastructure IoT data sources and predictive analytics for improved safety, performance, and reliability. With the incorporation of SPIDA, the reach of grid digital twins can now extend to the utility pole networks and structures, which deliver the environmentally vulnerable “last mile” of critical infrastructure for vital energy and communications.
Leading electric utilities including Ameren, EPCOR, Nashville Electric Service (NES), and Southern California Edison (SCE), engineer the effectiveness and resilience of their overhead systems by applying SPIDA’s software. SPIDA’s utility pole solutions include SPIDAcalc for capturing, modeling, and optimizing overhead transmission and distribution assets for structural loading; SPIDAsilk to analyze cable sag and tension design for physical and ambient properties for precise wire tension and conductor installation; and SPIDAstudio , a cloud-based platform that centrally tracks and manages the asset health and physical condition of overhead systems.
“As the rapid expansion of renewable energy sources and greater demand created by electric vehicles increasingly stresses our grid infrastructure, and for 5G-enabled broadband rollout, grids’ utility poles are ‘priceless’ for sustainably advancing infrastructure,” said Alan Kiraly, senior vice president, asset and network performance, Bentley Systems. “We are very pleased to welcome our new SPIDA colleagues to Bentley Systems and to OpenUtilities, and we look forward to further integrating and globalizing SPIDA software, already known as the trusted stalwart for energy distribution engineers in their essential work to improve grid performance and resilience.”
Brett Willitt, president of SPIDA Software, said, “Our vision with SPIDA has always been to provide a complete and open solution for maintaining and improving the health and integrity of our users’ power and communication overhead infrastructure assets. Within the Bentley team, we look forward to accelerating grid digital twin solutions, which leverage our industry domain experience and incorporate SPIDA structural analyses. Existing and future SPIDA users can look forward with confidence to leveraging grid digital twins as they upgrade, modify, expand, and manage their overhead systems.”
The acquisition of SPIDA Software, which is not material to Bentley’s financial results, will add 26 colleagues in North America. 7 Mile Advisors advised SPIDA’s management and shareholders in the transaction.
Video Link: SPIDAcalc
Video Caption: SPIDAcalc is the utility industry’s leading structural analysis software.
About Bentley Systems
Bentley Systems (Nasdaq: BSY) is the infrastructure engineering software company. We provide innovative software to advance the world’s infrastructure – sustaining both the global economy and environment. Our industry-leading software solutions are used by professionals, and organizations of every size, for the design, construction, and operations of roads and bridges, rail and transit, water and wastewater, public works and utilities, buildings and campuses, and industrial facilities. Our offerings include MicroStation -based applications for modeling and simulation, ProjectWise for project delivery, AssetWise for asset and network performance, and the iTwin platform for infrastructure digital twins. Bentley Systems employs more than 4,000 colleagues and generates annual revenues of more than $800 million in 172 countries. www.bentley.com
© 2021 Bentley Systems, Incorporated. Bentley, the Bentley logo, AssetWise, iTwin, MicroStation, ProjectWise, OpenUtilities, SPIDA, SPIDACalc, SPIDAsilk, and SPIDAstudio are either registered or unregistered trademarks or service marks of Bentley Systems, Incorporated or one of its direct or indirect wholly owned subsidiaries. All other brands and product names are trademarks of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210614005811/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom